Skip to content

Aura Biosciences, Inc. AURA Change in Other Assets

Change in Other Assets at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$1.05M+1,152%
UroGen Pharma logo
UroGen PharmaURGN
$2.33M+1,170%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$3.03M-254%
CG Oncology logo
CG OncologyCGON
$8.07M+1,377%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0+100%
Nuvation Bio logo
Nuvation BioNUVB
-$3.78M-2,509%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s change in other assets?
Aura Biosciences, Inc. (AURA) reported change in other assets of $46K in Q1 2026.
How has Aura Biosciences, Inc.'s change in other assets changed year-over-year?
Aura Biosciences, Inc.'s change in other assets increased by 108.9% year-over-year, from -$518K to $46K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.